James Kuo

Last updated

James Kuo is founder, CEO and Chairman of the Board of Salt Lake City-based BioMicro Systems, a company that makes research tools that control fluids by using hydrophilic (water-attracting) and hydrophobic (water-repelling) materials instead disruptive mechanical or electrical components. [1]

Early life and career

Kuo was born in Taiwan and came to the United States at the age of three. He earned an undergraduate degree at Haverford College in Haverford, Pa., a medical degree at University of Pennsylvania, and an MBA at the Wharton School, University of Pennsylvania. [2]

Kuo launched his career by combining his medical degree with his MBA to become a guru in the high-stakes business of discovering and developing promising drug candidates.

At the age of 27, Kuo was already director of a $380 million fund at America's leading biotech venture capital firm. He helped launch Human Genome Sciences and Genetic Therapy Inc. Five years later he became CEO of Discovery Laboratories, an unfunded startup, and within six months raised $22 million through private placement. He then became Managing Director of Venture Analysis at HealthCare Ventures, a $378 million venture fund. In 2001 he became CEO of Microbiotix, Inc. Earlier in his career Kuo held senior business development positions at Pfizer, Genset Corporation and Myriad Genetics. Kuo also serves on the board of DOR BioPharma (AMEX: DOR), among other positions. [3]

In February 2010, Kuo was appointed as Chairman, CEO and President of Adeona Pharmaceuticals, Inc. [4]

Related Research Articles

Columbia Business School

Columbia Business School (CBS) is the business school of Columbia University in the City of New York in Manhattan, New York City. Established in 1916, Columbia Business School is one of six Ivy League business schools and is one of the oldest business schools in the world. In 2021, it was ranked as the 7th best business school.

Brook Byers

Brook Byers is a senior partner at Kleiner Perkins Caufield & Byers and the brother of Stanford University Professor Tom Byers and Atlanta, Georgia engineering entrepreneur Ken Byers.

Arthur D. Levinson is an American businessman and is the current chairman of Apple Inc. (2011–present) and CEO of Calico. He is the former chief executive officer (1995–2009) and chairman (1999–2014) of Genentech.

Sheridan Gray Snyder OBE is an entrepreneur, venture capitalist, and philanthropist in the biotechnology industry. He is the founder and CEO of Biocatalyst, but also a "serial entrepreneur", a founder of Genzyme and many other companies. Snyder, who was the University of Virginia's best tennis player when he was studying for his BA in French and Romance Languages there in the 1960s, made "major contributions to the popularisation of tennis in the USA." He co-founded the National Junior Tennis League that reaches 250,000 inner-city young people and constructed a new tennis center at the University of Virginia.

Terry McGuire is a co-founder and general partner of Polaris Partners based in the Boston office. McGuire focuses on life sciences investments.

Fuad El-Hibri

Fuad Hibri is a German-American businessman and philanthropist, and founder of Emergent BioSolutions.

Ross School of Business Business school of the University of Michigan

The Stephen M. Ross School of Business is a business school operated by the University of Michigan. It offers bachelor's, master's, and doctoral degrees, as well as an executive education program. Its Bachelor of Business Administration (BBA), Master of Business Administration (MBA), and Executive Education programs have been ranked among the top in the U.S. and the world. Ross also offers dual degrees with other University of Michigan colleges and schools. The Distinguished Leader Certificate is offered by the Executive Education program.

Christoph Westphal, M.D., Ph.D., is a biomedical entrepreneur.

Phillip Frost is an American entrepreneur.

Joseph Jimenez

Joseph Jimenez is the former CEO of the American Swiss pharmaceutical company Novartis.

Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.

Richard B. Hollis

Richard B. Hollis is the founder, chairman, and CEO of Holonis, Inc., a San Diego-based software company. Hollis had previously founded Hollis-Eden Pharmaceuticals, a San Diego-based pharmaceutical company, in 1994.

BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland. Therapeutic opportunities are identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products.

Henri Termeer

Henri A. Termeer was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, alumni. Termeer is "connected to 311 board members in 17 different organizations across 20 different industries" He has the legacy of being the "longest-serving CEO in the biotechnology industry.

Benad Goldwasser, M.D., MBA is a urologic surgeon, inventor, entrepreneur and venture capital investor. During his business career he served as CEO and Active Chairman in a number of healthcare related companies.

David Lucchino

David L. Lucchino is co-founder and CEO of Frequency Therapeutics, a biotechnology company.

Jeffrey Leiden CEO of biotechnology company

Jeffrey Leiden, M.D., Ph.D. is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020.

William Rastetter

William H. Rastetter, a scientist, entrepreneur and venture capitalist, is the chair of Neurocrine Biosciences, of Fate Therapeutics, and of Daré Bioscience, Inc. in San Diego, California. He is a founding board member and investor in GRAIL, Inc. in Menlo Park, California, and served for a period as the company's interim CEO (2017) and chair (2017-2018). Rastetter is also a director of Regulus Therapeutics. He was a partner in the venture firm Venrock (2006-2013), and a trustee at Caltech (2015-2018). He has served as a director (1998-2016) and as chair of Illumina (2005-2016). He advised SVB Leerink (2014-2019) and currently advises Illumina Ventures.

Christopher Henney is a British-American biotechnology company executive and board member. In 1980, he co-founded Immunex Corp., which was later acquired by Amgen Inc.

References

  1. ↑ "James Kuo Founder, CEO and Chairman of the Board of BioMicro Systems | Top Asian American Professionals". Goldsea. Retrieved 2012-02-21.
  2. ↑ "San Diego Metropolitan - 40 Under 40 - September 2001". Sandiegometro.archives.whsites.net. Archived from the original on 2012-05-01. Retrieved 2012-02-21.
  3. ↑ Beers, Heather. "Articles". Utah Business. Archived from the original on 2012-09-14. Retrieved 2012-02-21.
  4. ↑ "Adeona Pharmaceuticals (AEN) Appoints James S. Kuo, M.D., M.B.A., as Chairman, CEO and President". FierceBiotech. Retrieved 2012-02-21.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.